Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer.

Miller TW, Rexer BN, Garrett JT, Arteaga CL
Breast Cancer Res. 2011 13 (6): 224

PMID: 22114931 · PMCID: PMC3315683 · DOI:10.1186/bcr3039

MeSH Terms (13)

Animals Antineoplastic Agents Breast Neoplasms Disease Progression Enzyme Inhibitors Female Humans Mutation Phosphatidylinositol 3-Kinases Receptor, ErbB-2 Receptors, Estrogen Receptors, Progesterone Signal Transduction

Connections (3)

This publication is referenced by other Labnodes entities: